Log In
Print
BCIQ
Print
Print this Print this
 

RQ-00310941

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionSerotonin (5-HT2B) antagonist
Molecular Target Serotonin (5-HT2B) receptor
Mechanism of ActionSerotonin (5-HT2B) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat diarrhea-predominant irritable bowel syndrome (IBS-D)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today